Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 31,636 articles published since 2008
|||| 49 

These are the 31636 published articles about Pancreatic Neoplasms that originated from Worldwide during 2008-2019.
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
226 Editorial Endoscopic Ultrasound-Guided Fine-Needle Aspiration of Gastrointestinal and Pancreatic Tumors: Is Negative Pressure Helpful or Does It Suck? 2016

Kawakami, Hiroshi / Kubota, Yoshimasa / Sakamoto, Naoya. ·Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648, Japan. hiropon@med.hokudai.ac.jp. · Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Kita 14, Nishi 5, Kita-ku, Sapporo, 060-8648, Japan. ·Dig Dis Sci · Pubmed #26462486.

ABSTRACT: -- No abstract --

227 Editorial The evolving field of genomic biomarkers to characterize pancreatic cystic neoplasia by EUS-guided FNA. 2016

Gleeson, Ferga C / Levy, Michael J. ·Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. ·Gastrointest Endosc · Pubmed #26227930.

ABSTRACT: -- No abstract --

228 Editorial MiRNAs as biomarkers of high-risk pancreatic cysts: a possible holy grail for the early detection of pancreatic cancer. 2015

Permuth, Jennifer B / Georgeades, Christina / Malafa, Mokenge. ·Department of Cancer Epidemiology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Department of Gastrointestinal Oncology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Morsani College of Medicine, University of South Florida, Tampa, FL, USA. ·Future Oncol · Pubmed #26549701.

ABSTRACT: -- No abstract --

229 Editorial Ask someone who cares: Caregiver surveys as a means of improving the management of pancreatic cancer patients. 2015

Turner, Richard C. ·University of Tasmania, School of Medicine, Australia. Electronic address: richard.turner@utas.edu.au. ·Pancreatology · Pubmed #26547593.

ABSTRACT: -- No abstract --

230 Editorial A New Scalpel for the Treatment of Pancreatic Cancer: Targeting Stromal-Derived STAT3 Signaling. 2015

Cowan, Robert W / Maitra, Anirban / Rhim, Andrew D. ·Division of Gastroenterology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan. · Departments of Pathology and Translational Molecular Pathology, Sheikh Ahmed Pancreatic Cancer Research Center, University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Gastroenterology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: arhim@med.umich.edu. ·Gastroenterology · Pubmed #26526714.

ABSTRACT: -- No abstract --

231 Editorial Prediction in pancreatic cancer. 2015

Wylie, Neil / Koea, Jonathan B. ·Department of Surgery, North Shore Hospital, Auckland, New Zealand. ·ANZ J Surg · Pubmed #26498563.

ABSTRACT: -- No abstract --

232 Editorial Advanced pancreatic cancer - how to choose an adequate treatment option. 2015

Korkeila, Eija A. ·Eija A Korkeila, Department of Oncology, Turku University Hospital and University of Turku, 20521 Turku, Finland. ·World J Gastroenterol · Pubmed #26478662.

ABSTRACT: The prognosis of pancreatic adenocarcinoma is poor, making it one of the leading causes of cancer-related death. The 5-year overall survival rate remains below 5% and little progress is made during the past decade. Only about 10%-20% of patients are eligible for curative-intent surgery and the majority end up having recurring disease even after radical surgery and postoperative adjuvant chemotherapy. Chemotherapy in metastatic disease is palliative at best, aiming at disease and symptom control and prolongation of life. Treatment always causes side effects, the degree of which varies from patient to patient, depending on the patient's general condition, concomitant morbidities as well as on the chosen treatment modality. Why is pancreatic cancer so resistant to treatment? How to best help the patient to reach the set treatment goals?

233 Editorial Pancreatic EUS: the linear strikes back. 2015

Petrone, Maria Chiara / Arcidiacono, Paolo Giorgo. ·Endosonography Unit, Gastroenterology and Gastrointestinal Endoscopy Unit, San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan, Italy. · Gastrointestinal Endoscopy Unit, Gastroenterology and Gastrointestinal Endoscopy Unit, San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan, Italy. ·Gastrointest Endosc · Pubmed #26471999.

ABSTRACT: -- No abstract --

234 Editorial Better Biomarkers for Pancreatic Diseases. 2015

Whitcomb, David C. ·From the Departments of Medicine, Cell Biology & Molecular Physiology, and Human Genetics, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh/UPMC, Pittsburgh, PA. ·Pancreas · Pubmed #26465944.

ABSTRACT: -- No abstract --

235 Editorial Rac1 GTPase in pancreatic cancer. 2015

Yan, Ying / Ouellette, Michel M. ·Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198, USA. · Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE 68198, USA. ·Aging (Albany NY) · Pubmed #26420819.

ABSTRACT: -- No abstract --

236 Editorial Disconnect between EMT and metastasis in pancreas cancer. 2015

Whittle, Martin C / Hingorani, Sunil R. ·Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Division of Medical Oncology, University of Washington School of Medicine, Seattle, WA, USA. ·Oncotarget · Pubmed #26387140.

ABSTRACT: -- No abstract --

237 Editorial International guidelines for the management of pancreatic intraductal papillary mucinous neoplasms. 2015

Goh, Brian K P. ·Brian KP Goh, Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, Singapore 169856, Singapore. ·World J Gastroenterol · Pubmed #26379390.

ABSTRACT: The management of intraductal papillary mucinous neoplasms (IPMN) is presently evolving as a result of the improved understanding of the natural history and biological behavior of the different pancreatic cystic neoplasms; and better preoperative diagnosis of these neoplasms due to advancement in preoperative diagnostic tools. International consensus guidelines for the management of IPMN were first formulated in 2006 and subsequently revised in 2012. Both these guidelines were constructed based on expert opinion and not on robust clinical data. The main limitation of the original Sendai guidelines was that it had a low positive predictive value resulting in many benign neoplasms being resected. Hence, these guidelines were revised in 2012. However, although the updated guidelines resulted in an improvement in the positive predictive value over the Sendai Guidelines, the results of several studies validating these guidelines demonstrated that its positive predictive value remained low. Furthermore, although both guidelines were associated with high negative predictive values, several investigators have demonstrated that some malignant IPMNs may be missed. Finally, it is imperative to emphasize that major considerations when managing a patient with IPMN including the patient's surgical risk, life-expectancy and even cost of investigations are not taken into account in current guidelines. The management of a patient with IPMN should be individualized and tailored according to a patient's risk benefit profile for resection vs surveillance.

238 Editorial Targeting interleukin-17 receptors. 2015

Lee, Wen-Hwa / Wu, Heng-Hsiung / Huang, Chun-Kai. ·Graduate Institute of Clinical Medicine, China Medical University, Taichung, Taiwan. · Genomics Research Center, Academia Sinica, Taipei, Taiwan. ·Oncotarget · Pubmed #26285835.

ABSTRACT: -- No abstract --

239 Editorial Cyst fluid: moving beyond the carcinoembryonic antigen. 2015

Brugge, William R. ·Pancreas Biliary Center, Massachusetts General Hospital, Boston, Massachusetts, USA. ·Gastrointest Endosc · Pubmed #26264436.

ABSTRACT: -- No abstract --

240 Editorial Luciano Pavarotti (1935-2007). 2015

Rössner, S. ·Professor Emeritus. stephan@rossner.se. ·Obes Rev · Pubmed #26255651.

ABSTRACT: -- No abstract --

241 Editorial Pancreatic Cancer. 2015

Wolpin, Brian M. ·Center for Gastrointestinal Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: bwolpin@partners.org. ·Hematol Oncol Clin North Am · Pubmed #26226911.

ABSTRACT: -- No abstract --

242 Editorial Intraductal Radiofrequency Ablation (RFA) for Pancreatic Cancer: Getting in Under the Wire? 2015

Brauer, Brian C. ·Division of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, 1635 Aurora Ct, Mailstop F-735, Room AIP 2.031, Aurora, CO, 80045, USA. Brian.brauer@ucdenver.edu. ·Dig Dis Sci · Pubmed #26209042.

ABSTRACT: -- No abstract --

243 Editorial Highlights of topic "Pancreatic neuroendocrine tumors update". 2015

Ito, Tetsuhide. ·Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. ·J Hepatobiliary Pancreat Sci · Pubmed #26199177.

ABSTRACT: -- No abstract --

244 Editorial Evaluating Research on the Safety of Medical Therapies: The Responsibility of Journals to the Health of the Public. 2015

Fontanarosa, Phil B / Bauchner, Howard / Golub, Robert M. ·Dr Fontanarosa is Executive Deputy Editor, Dr Bauchner is Editor in Chief, and Dr Golub is Deputy Editor, JAMA. ·JAMA · Pubmed #26197183.

ABSTRACT: -- No abstract --

245 Editorial The Safety of Prescription Drugs. 2015

Sharfstein, Joshua M / Kesselheim, Aaron S. ·Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. · The Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts3Harvard Medical School, Boston, Massachusetts. ·JAMA · Pubmed #26197182.

ABSTRACT: -- No abstract --

246 Editorial Current status and progress of pancreatic cancer in China. 2015

Lin, Quan-Jun / Yang, Feng / Jin, Chen / Fu, De-Liang. ·Quan-Jun Lin, Feng Yang, Chen Jin, De-Liang Fu, Department of Pancreatic Surgery, Pancreatic Disease Institute, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China. ·World J Gastroenterol · Pubmed #26185370.

ABSTRACT: Cancer is currently one of the most important public health problems in the world. Pancreatic cancer is a fatal disease with poor prognosis. As in most other countries, the health burden of pancreatic cancer in China is increasing, with annual mortality rates almost equal to incidence rates. The increasing trend of pancreatic cancer incidence is more significant in the rural areas than in the urban areas. Annual diagnoses and deaths of pancreatic cancer in China are now beyond the number of cases in the United States. GLOBOCAN 2012 estimates that cases in China account for 19.45% (65727/337872) of all newly diagnosed pancreatic cancer and 19.27% (63662/330391) of all deaths from pancreatic cancer worldwide. The population's growing socioeconomic status contributes to the rapid increase of China's proportional contribution to global rates. Here, we present an overview of control programs for pancreatic cancer in China focusing on prevention, early diagnosis and treatment. In addition, we describe key epidemiological, demographic, and socioeconomic differences between China and developed countries. Facts including no nationwide screening program for pancreatic cancer, delay in early detection resulting in a late stage at presentation, lack of awareness of pancreatic cancer in the Chinese population, and low investment compared with other cancer types by government have led to backwardness in China's pancreatic cancer diagnosis and treatment. Finally, we suggest measures to improve health outcomes of pancreatic cancer patients in China.

247 Editorial Protein kinase D enzymes: novel kinase targets in pancreatic cancer. 2015

Liou, Geou-Yarh / Storz, Peter. ·a Department of Cancer Biology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA. ·Expert Rev Gastroenterol Hepatol · Pubmed #26174103.

ABSTRACT: Pancreatic ductal adenocarcinoma (PDA) is characterized by advanced stage desmoplastic tumors with a high prevalence of genetic abnormalities. Occurrence of PDA is linked to activating Kras mutations and aberrant epidermal growth factor receptor signaling, leading to additional activation of wild-type Kras. As Kras is difficult to target, there is a constant need to identify novel targets acting downstream of this molecule in driving the formation or progression of PDA. Recently, it was shown that protein kinase D enzymes not only are increasingly expressed in PDA but also causatively linked to the development and progression of this cancer. They act downstream of both mutant Kras and growth factors and therefore may represent ideal novel targets.

248 Editorial IER3 in pancreatic carcinogenesis. 2015

Molejon, Maria Inés / Iovanna, Juan Lucio. ·Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France. ·Oncotarget · Pubmed #26158545.

ABSTRACT: -- No abstract --

249 Editorial Very long-term survival in pancreatic cancer. 2015

Molin, Marco Dal / Wood, Laura D. ·Gastrointestinal and Liver Pathology Department, Johns Hopkins University, Baltimore, MD, USA. ·Aging (Albany NY) · Pubmed #26143583.

ABSTRACT: -- No abstract --

250 Editorial Pulling the Trigger on Pancreatic Cysts. 2015

Othman, Mohamed O / Topazian, Mark D. ·Baylor College of Medicine, Houston, Texas. · Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, Minnesota. ·Clin Gastroenterol Hepatol · Pubmed #26122760.

ABSTRACT: -- No abstract --

Back · Next